ChemicalBook > Product Catalog >API >Antineoplastic agents >Tinib Antineoplastic drugs >Tandutinib

Tandutinib

Tandutinib Structure
CAS No.
387867-13-2
Chemical Name:
Tandutinib
Synonyms
CS-309;MLN 518;CT 53518;NSC726292;Tandutinib;Unii-E1io3icj9a;CT53518; MLN518;Tandutinib(TINIBS);MLN518, Tandutinib;Tandutinib (MLN518)
CBNumber:
CB31011758
Molecular Formula:
C31H42N6O4
Molecular Weight:
562.7
MOL File:
387867-13-2.mol
Modify Date:
2024/6/7 20:51:53

Tandutinib Properties

Melting point 177-178°C
Boiling point 769.5±60.0 °C(Predicted)
Density 1.213±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Store in freezer, under -20°C
solubility Chloroform (Slightly), Methanol (Slightly)
pka 13.39±0.70(Predicted)
form Solid
color White to Off-White
CAS DataBase Reference 387867-13-2(CAS DataBase Reference)

Tandutinib price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) SML2672 Tandutinib hydrochloride ≥98% (HPLC) 387867-13-2 25MG ₹5860.8 2022-06-14 Buy
Sigma-Aldrich(India) SML2672 Tandutinib hydrochloride ≥98% (HPLC) 387867-13-2 100MG ₹11821.5 2022-06-14 Buy
Product number Packaging Price Buy
SML2672 25MG ₹5860.8 Buy
SML2672 100MG ₹11821.5 Buy

Tandutinib Chemical Properties,Uses,Production

Description

Tandutinib is a potent antagonist of platelet-derived growth factor receptor β (PDGFRβ), FLT3, and c-Kit (IC50 = 200, 220, and 170 nM, respectively). It less potently inhibits macrophage colony-stimulating factor 1 receptor (IC50 = 3.4 μM) and does not significantly inhibit other tyrosine or serine/threonine kinases. Tandutinib blocks the growth of cells expressing an internal tandem duplication within the juxtamembrane domain of the FLT3 receptor, found in some acute myelogenous leukemia cells. It also impairs the growth of colon cancer cells through its actions on the c-Kit receptor. Tandutinib reverses multidrug resistance in vitro by impairing the efflux activity of the multidrug resistance protein 7.

Chemical Properties

White Solid

Uses

An oral, small-molecule inhibitor of FLT3 for the treatment of AML (acute myelogenous leukemia) and other cancer indications. The drug exhibited limited activity as a single agent in phase I and II clinical trials in patients with AML and myelody

Definition

ChEBI: An N-arylpiperazine that is piperazine in which the hydrogen attached to the nitrogen at position 1 is replaced by a 6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl group, while the hydrogen attached to the nitrogen at position 4 s replaced by a (p-isopropoxyphenyl)aminocarbonyl group. Tandutinib is an inhibitor of tyrosine kinases FLT3, PDGFR and KIT.

Tandutinib Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 170)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Manus Aktteva +91 (79) 6512-3395 New Delhi, India 581 34 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Sinoway Industrial co., ltd. 0592-5800732; +8613806035118 China 990 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
Xiamen AmoyChem Co., Ltd +86-592-6051114 +8618959220845 China 6387 58 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49391 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29826 58 Inquiry
SIMAGCHEM CORP +86-13806087780 China 17367 58 Inquiry
Tandutinib 1-Piperazinecarboxamide, 4-(6-methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)- 4-(6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl)piperazine-1-carboxylic acid (4-isopropoxyphenyl)amide Unii-E1io3icj9a Tandutinib(CT 53518) Tandutinib (MLN518) CT53518; MLN518 Tandutinib(TINIBS) (4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide 4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide CT 53518 MLN 518 Tandutinib for research N-(4-isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1-carboxamide NSC726292 (4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide Tandutinib(MLN518) 4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-Methylethoxy)phenyl]- N-(4-Isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1- MLN518; CT53518; MLN 518; CT 53518; MLN-518; CT-53518; Tandutinib (CT53518, MLN518) CS-309 Tandutinib(MLN518, CT53518) Tandutinib USP/EP/BP Tandutinib (MLN518, CT53518, NSC-726292) 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(... MLN518, Tandutinib Tandutinib CT53518 MLN518 CT-53518 MLN-518 387867-13-2 C31H42N6O4 C27H31Br2ClN4O2 Inhibitors ZUBRIN API Intermediates & Fine Chemicals Pharmaceuticals Tyrosine Kinase Inhibitors